Jan Burger
Professor · University of Texas M D Anderson Cancer Center
Credentials: · · ·
History
- 1999–2005
- 1995–1996
- 1990–1994
Doctor of Medicine
Research
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia
New England Journal of Medicine · 2013 · 1,914 citations
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
New England Journal of Medicine · 2015 · First of 35 authors · 1,331 citations
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
Review · Blood · 2006 · First of 2 authors · Corresponding · 981 citations
137 papers · 4 as a fellow
114 papers
- SO
113 papers
- MK
97 papers
94 papers
- ZE
74 papers
73 papers
51 papers
Clinical trials
- 2020–2027
Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
- 2020–2027
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
- 2018–2024
Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL)
Principal investigator · Completed · Phase 2
M.D. Anderson Cancer Center
- 2014–2015
Ibrutinib in Treating Patients With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia
Principal investigator · Terminated · Phase 2
National Cancer Institute (NCI)